Literature DB >> 12175991

Bax-induction gene therapy of pancreatic cancer.

Elissa C Pirocanac1, Rounak Nassirpour, Meng Yang, Jinwei Wang, Stephanie R Nardin, Jian Gu, Bingliang Fang, A R Moossa, Robert M Hoffman, Michael Bouvet.   

Abstract

BACKGROUND: Bax is a strong pro-apoptotic gene that induces programmed cell death when expressed. Human telomerase reverse transcriptase (hTERT) is the catalytic subunit for telomerase, an enzyme found to be active in more than 85% of human cancers. Recently, a binary adenoviral system (Ad/GT-Bax + Ad/hTERT-GV16) was constructed using the hTERT promoter to induce Bax gene expression in tumor cells.
METHODS: To test whether human pancreatic tumor cells would respond to this system of Bax-induced apoptosis, we compared the effects of Bax gene induction with that of LacZ gene induction using the same binary system.
RESULTS: Lysates of the human pancreatic cell lines PANC-28, MIA PaCa-2, and BxPC-3 showed significantly elevated levels of human telomerase using the PCR-based TRAP assay. As early as 24 h after treatment with Bax-induction gene therapy, growth inhibition was observed. Overexpression of the Bax protein was confirmed by Western blotting. Extensive apoptosis on FACS analysis at 48 h was seen after Bax induction. In addition, cytosolic cytochrome c levels increased compared to mitochondrial levels after Bax induction. Levels of caspase-3, a key downstream enzyme involved in apoptosis, also increased significantly compared to controls after treatment. None of these effects were seen with LacZ.
CONCLUSION: Our results suggest that the binary adenoviral vector system, Ad/GT-Bax + Ad/hTERT-GV16, induces high levels of Bax expression that induce apoptosis in human pancreatic cancer cells.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12175991     DOI: 10.1006/jsre.2002.6473

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  14 in total

1.  Effects of combined siRNA-TR and -TERT on telomerase activity and growth of bladder transitional cell cancer BIU-87 cells.

Authors:  Wen Cheng; Zhifeng Wei; Jianping Gao; Zhengyu Zhang; Jingping Ge; Kangzhen Jing; Feng Xu; Peng Xie
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2010-06-17

2.  The role of Bcl-2 family members in the progression of cutaneous melanoma.

Authors:  Jason A Bush; Gang Li
Journal:  Clin Exp Metastasis       Date:  2003       Impact factor: 5.150

3.  Oil A induces apoptosis of pancreatic cancer cells via caspase activation, redistribution of cell cycle and GADD expression.

Authors:  Mi-Lian Dong; Yue-Chun Zhu; John V Hopkins
Journal:  World J Gastroenterol       Date:  2003-12       Impact factor: 5.742

4.  Relationship between telomerase activity and its subunit expression and inhibitory effect of antisense hTR on pancreatic carcinoma.

Authors:  Jia-Hua Zhou; Hong-Mei Zhang; Quan Chen; Dong-Dong Han; Fei Pei; Li-Shan Zhang; De-Tong Yang
Journal:  World J Gastroenterol       Date:  2003-08       Impact factor: 5.742

5.  Red oil A5 inhibits proliferation and induces apoptosis in pancreatic cancer cells.

Authors:  Mi-Lian Dong; Xian-Zhong Ding; Thomas E Adrian
Journal:  World J Gastroenterol       Date:  2004-01       Impact factor: 5.742

Review 6.  Novel gene therapy approaches to pancreatic cancer.

Authors:  Matthew H Katz; Michael Bouvet
Journal:  Int J Gastrointest Cancer       Date:  2003

Review 7.  Apoptosis: targets in pancreatic cancer.

Authors:  Sabine Westphal; Holger Kalthoff
Journal:  Mol Cancer       Date:  2003-01-07       Impact factor: 27.401

8.  pERK1/2 silencing sensitizes pancreatic cancer BXPC-3 cell to gemcitabine-induced apoptosis via regulating Bax and Bcl-2 expression.

Authors:  Min Wang; Xingjiao Lu; Xueguang Dong; Fengyun Hao; Zimin Liu; Guangzhen Ni; Dong Chen
Journal:  World J Surg Oncol       Date:  2015-02-21       Impact factor: 2.754

9.  Lack of association between Bax promoter (-248G>A) single nucleotide polymorphism and susceptibility towards cancer: evidence from a meta-analysis.

Authors:  Sushil Kumar Sahu; Tathagata Choudhuri
Journal:  PLoS One       Date:  2013-10-17       Impact factor: 3.240

10.  Polymorphisms of BCL2 and BAX Genes Associate with Outcomes in Advanced Non-small cell lung cancer Patients treated with platinum-based Chemotherapy.

Authors:  Yu Peng; Linang Wang; Yi Qing; Chongyi Li; Tao Ren; Qing Li; Mengxia Li; Shiheng Zhang; Jinglu Shan; Ge Wang; Zhenzhou Yang; Dong Wang
Journal:  Sci Rep       Date:  2015-12-10       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.